{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:04Z","timestamp":1787169844833,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chronic hepatitis C (CHC) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide. This study aimed to determine rates and predictors of survival among Omani patients with CHC at a tertiary hospital in Muscat, Oman.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This ambidirectional cohort study included all CHC patients who presented to the Sultan Qaboos University Hospital between January 2009 and December 2017. Baseline demographic, clinical, laboratory, and radiological data were analyzed. Patients were followed-up until death or the endpoint of the study (April 2022) to determine survival and associations with other parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 702 CHC patients were included, of which 398 (56.7%) were under 50 years of age and 477 (67.9%) were male. Overall, 180 patients (25.6%) died by the study endpoint. The mean duration of follow-up was 93.3 \u00b1 48.0 months. The 5-year survival rate was estimated to be 80.5%, while the 10-year survival was 73%. Sustained virological response and the absence of diabetes mellitus, chronic kidney disease, HCC, or other malignancies were associated with significantly better overall survival. The 3- and 5-year survival rate of patients with hepatitis C virus (HCV)-related HCC was 46.5% and 27.6%, respectively, with a median survival of 29.5 months. Co-infection with hepatitis B was associated with poor survival among this subgroup; conversely, early HCV screening and the presence of a single HCC lesion were associated with better overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>National policies for early CHC screening and rapid treatment are needed to improve survival rates in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_201_23","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T03:34:39Z","timestamp":1695008079000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman"],"prefix":"10.4103","volume":"30","author":[{"given":"Halima H.","family":"Al-Shuaili","sequence":"first","affiliation":[{"name":"Department of Medicine, Ibri Hospital, Ibri, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said A.","family":"Al-Busafi","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al-Naamani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Armed Forces Hospital, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakariya","family":"Al-Naamani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"e0165722","DOI":"10.1371\/journal.pone.0165722","article-title":"Survival analysis of single large (>5 cm) hepatocellular carcinoma patients:BCLC A versus B","volume":"11","author":"Cho","year":"2016","journal-title":"PloS One"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J Hepatol"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1186\/s12885-019-6040-3","article-title":"Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma","volume":"19","author":"Park","year":"2019","journal-title":"BMC Cancer"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.510280238","article-title":"Clinical outcome of hepatitis C as a function of mode of transmission","volume":"28","author":"Gordon","year":"1998","journal-title":"Hepatology"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510290401","article-title":"Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis","volume":"29","author":"Hourigan","year":"1999","journal-title":"Hepatology"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/liv.13466","article-title":"Effect of smoking on survival of patients with hepatocellular carcinoma","volume":"37","author":"Kolly","year":"2017","journal-title":"Liver Int"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/liv.13921","article-title":"Prognostic factors of survival in HIV\/HCV co-infected patients with hepatocellular carcinoma:The CARCINOVIC cohort","volume":"39","author":"Gelu-Simeon","year":"2019","journal-title":"Liver Int"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.18295\/squmj.2017.17.04.005","article-title":"Epidemiology of chronic hepatitis C infections at a tertiary care centre in Oman","volume":"17","author":"Al-Busafi","year":"2017","journal-title":"Sultan Qaboos Univ Med J"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.2014.12627","article-title":"Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population","volume":"312","author":"van der Meer","year":"2014","journal-title":"JAMA"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"e4594","DOI":"10.1097\/MD.0000000000004594","article-title":"The clinical outcomes of chronic hepatitis C in South Korea:A prospective, multicenter cohort study","volume":"95","author":"Ok","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"R17-20240829","first-page":"664","article-title":"Hepatitis C screening","volume":"14","author":"Joshi","year":"2014","journal-title":"Ochsner J"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/j.ajkd.2012.08.040","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease","volume":"61","author":"Fabrizi","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0272-6386(03)00024-6","article-title":"Hepatitis C virus-associated tubulointerstitial injury","volume":"41","author":"Kasuno","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000093632","article-title":"Insulin resistance, hyperinsulinemia, and renal injury:Mechanisms and implications","volume":"26","author":"Sarafidis","year":"2006","journal-title":"Am J Nephrol"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.nefroe.2020.06.005","article-title":"The impact of antiviral therapy for HCV on kidney disease:A systematic review and meta-analysis","volume":"40","author":"Fabrizi","year":"2020","journal-title":"Nefrologia (Engl Ed)"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jvh.12413","article-title":"A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection","volume":"22","author":"Park","year":"2015","journal-title":"J Viral Hepat"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.27664","article-title":"Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans","volume":"61","author":"Molnar","year":"2015","journal-title":"Hepatology"},{"key":"R24-20240829","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2893.2012.01633.x","article-title":"Impact of hepatitis C on survival in dialysis patients:A link with cardiovascular mortality?","volume":"19","author":"Fabrizi","year":"2012","journal-title":"J Viral Hepat"},{"key":"R25-20240829","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/jgh.14003","article-title":"Impact of diabetes mellitus and hepatitis B virus co-infection on patients with chronic hepatitis C:A territory-wide cohort study","volume":"33","author":"Subramaniam","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R26-20240829","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3748\/wjg.v23.i9.1697","article-title":"Diabetes mellitus, insulin resistance and hepatitis C virus infection:A contemporary review","volume":"23","author":"Desbois","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R27-20240829","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R28-20240829","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer surviva 2000-14 (CONCORD-3):Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"R29-20240829","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/jrms.JRMS_1017_18","article-title":"Predictors of 5 year survival rate in hepatocellular carcinoma patients","volume":"24","author":"Sarveazad","year":"2019","journal-title":"J Res Med Sci"},{"key":"R30-20240829","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3349\/ymj.2006.47.1.105","article-title":"The actual five-year survival rate of hepatocellular carcinoma patients after curative resection","volume":"47","author":"Lee","year":"2006","journal-title":"Yonsei Med J"},{"key":"R31-20240829","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2147\/CMAR.S192896","article-title":"Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis:A population-based study","volume":"11","author":"Wu","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R32-20240829","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<741::AID-CNCR3>3.0.CO;2-M","article-title":"Hepatocellular carcinoma and co-infection with hepatitis B and C:Making a difficult situation worse","volume":"86","author":"Kurtz","year":"1999","journal-title":"Cancer"},{"key":"R33-20240829","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jhbp.466","article-title":"Survival rates after liver transplantation using hypertensive donor grafts:An analysis of the Scientific Registry of Transplant Recipients database","volume":"24","author":"Hu","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R34-20240829","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R35-20240829","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma:The BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R36-20240829","doi-asserted-by":"crossref","first-page":"296","DOI":"10.14218\/JCTH.2018.00016","article-title":"HBV-HCV coinfection:Viral interactions, management, and viral reactivation","volume":"6","author":"Mavilia","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"R37-20240829","doi-asserted-by":"crossref","first-page":"780887","DOI":"10.3389\/fmicb.2021.780887","article-title":"Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C virus:Prevalence, risk factors, pathogenesis, diagnosis, and treatment","volume":"12","author":"Shahriar","year":"2022","journal-title":"Front Microbiol"},{"key":"R38-20240829","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.5001\/omj.2021.99","article-title":"Risk factors for hepatitis B virus transmission in Oman","volume":"36","author":"Al-Busafi","year":"2021","journal-title":"Oman Med J"},{"key":"R39-20240829","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijid.2016.03.012","article-title":"Epidemiology of hepatitis C virus in the Arabian Gulf countries:Systematic review and meta-analysis of prevalence","volume":"46","author":"Mohamoud","year":"2016","journal-title":"Int J Infect Dis"},{"key":"R40-20240829","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jgh.12421","article-title":"Treatment of patients with dual hepatitis C virus and hepatitis B virus infection:Resolved and unresolved issues","volume":"29","author":"Liu","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R41-20240829","first-page":"477","article-title":"Medical tourism abroad:A new challenge to Oman's health system-Al Dakhilya region experience","volume":"11","author":"Al-Hinai","year":"2011","journal-title":"Sultan Qaboos Univ Med J"},{"key":"R42-20240829","doi-asserted-by":"crossref","first-page":"4251814","DOI":"10.1155\/2021\/4251814","article-title":"Living-donor liver transplant in Oman:A quantitative cross-sectional study of donors'experiences and challenges","volume":"2021","author":"Al Adawi","year":"2021","journal-title":"J Transplant"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_201_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:02Z","timestamp":1787166842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_201_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_201_23","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"2023-05-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}